Electrophoretic screening of (C57BL/6J x
In 1972, the first reports appeared of a new inborn error of metabolism in humans that was manifested as the combination of osteopetrosis and renal tubular acidosis (1) (2) (3) . Intracranial calcifications and mental retardation were later reported in association with this disorder (4) (5) (6) . On the basis of pedigree analysis, the inheritance pattern appeared to be that of an autosomal recessive mutation. Electrophoretic, chromatographic, and immunodiffusion studies performed on members of one of these families established that erythrocytes of the affected individuals were deficient in the carbonic anhydrase II (CA II) isozyme (7) . Codominant inheritance of this enzyme deficiency was compatible with the recessive inheritance of the disease (7) (8) (9) (10) . However, the clinical heterogeneity of affected humans remains unexplained. The inability to study CA II levels in kidney and bone has prevented a firm demonstration of the relationship between CA II deficiency in these tissues and the clinical disorder.
A CA II-deficient animal model promises to be useful in confirming the relationship between the enzyme deficiency and the clinical phenotype. In general, animal models of human genetic disorders have a great potential for elucidating the underlying mechanisms of disease and for developing effective therapeutic strategies to be used with humans. A number of such models have resulted from spontaneous mutations in several animal species (11) . A relatively recent development has been the induction of potentially useful mutations by using mutagens. As a result, mouse models of a-thalassemia (12, 13) , osteogenesis imperfecta (14) , polycythemia (15) , and glucose phosphate isomerase deficiency resulting in macrocytic anemiat have been reported.
The CA II gene of the mouse has been characterized, and its protein product is known to express genetic variability (16, 17) . In mice, the genes for CA I and CA II (Car-i and Car-2) are closely linked at the centromeric region of chromosome 3 (17) , and several allelic electrophoretic variants have been described at both loci; two of the CA II alleles, Car-2a and Car-2b, are characteristic of C57BL/6J and DBA/2J mice, respectively (17) .
In this report, we describe a null mutation of the Car-2b allele of a male DBA/2J mouse induced by the mutagen N-ethyl-N-nitrosourea (EtNU). Homozygotes for the new allele have a syndrome with some features of the human CA II deficiency.
MATERIALS AND METHODS
The mouse Car-2 null mutant was produced in a mutagenesis program in which a dose of EtNU at 200 mg/kg was-administered to DBA/2J male mice. Methods for dosing of animals with EtNU have been described (18, 19) .
The DBA/2J males were mated to C57BL/6J females 10 weeks or more after treatment to obtain progeny from germ cells that were exposed to EtNU as spermatogonia. Blood and kidney samples from the (C57BL/6J x DBA/2J)F1 progeny were screened for variations at 32 loci by starch gel electrophoresis and broad-range isoelectric focusing, as described elsewhere (18, 19) . CA II in F1 animals appears as two bands (i.e., CA Ila and CA Ilb) on the broad-range focusing gels.
The original F1 mutant was backcrossed to C57BL/6J
females. Intercrosses of carriers and additional backcrosses were also performed. The CA II phenotypes of all progeny were determined in blood samples by broad-range isoelectric focusing (19) or by electrophoresis on cellulose acetate (Cellogel, Whatman) at pH 5.4. Developmental curves were generated by weighing the mice several times a week. Their CA II phenotypes were determined after weaning.
Urine pH values were determined on the droplets voided when the mice were handled, using ColorpHast pH reagent strips accurate to ±+0.25 pH unit. Urine pH values were recorded while the mice were on a regular diet (Ralston Purina Lab Chow) with either tap water or various concentrations of NH4Cl administered in the drinking water to test their ability to adapt to an acid load (20 The presence of CA II proteins in various tissues was determined by immunodiffusion analysis. Tissues from normal and deficient animals were homogenized in 0.9o NaCl (1 g/ml) with a ground glass homogenizer; insoluble material was removed by centrifugation. Goat antisera prepared against mouse CA I or CA II were placed in the center wells of Ouchterlony plates, and the tissue homogenates and controls were placed in the surrounding wells. The plates were developed at 37TC for 3-7 hr.
Southern blots were prepared by standard techniques (21) . Total RNA was isolated by the guanidine isothiocyanate procedure (22) , and the technique for slot blots was adapted from standard techniques (21) . The CA II probe used for RNA transfer blotting and Southern analyses were pMCAII (17) . The phosphoglycerate kinase-1 (PGK-1) cDNA probe used as a control was pHPGK-7e (23) . Probes were radiolabeled by the random primer labeling method (24). .WU .
-CAlla -CAllb emoglobin RESULTS A (C57BL/6J x DBA/2J)F1 male mouse was identified as a variant by the absence of the band specified by the Car-2b allele ( Fig. 1 ) inherited from the DBA/2J male parent. The band specified by the Car-2a allele of the female parent was in the normal position on the focusing gel. All other loci screened in the blood and kidney samples from this animal were normal. The 32-locus electrophoretic profiles of the parents and the 6 siblings and 25 half-siblings of the mutant were entirely normal. In particular, the Car-2 bands were in the position appropriate for each strain.
The variant animal was backcrossed to C57BL/6J females. Female progeny from this backcross, presumably Car2a/Car-2n because of light Car-2a bands, were mated with the original F1 mutant and somewhat less than the predicted one-fourth of their progeny lacked any bands in the Car-2 region (Table 1 (Fig. 2A) . When a variety of tissues (i.e., kidney, stomach, brain, and large intestine) were compared between homozygous null and sibling wild-type mice for CA II antigen, no CA II was detected in the nulls (Fig. 2  A and B) . When these same tissues were tested for the CA I antigen, no differences were noted between the null homozygotes and their normal siblings (Fig. 2B) .
Quantitation of CA II mRNA by slot-blot analysis showed some variability in the CA II mRNA levels in a number of tissues of CA II-deficient mice (Fig. 3a) . Hybridization of the same slot blot with a human cDNA clone for the housekeeping enzyme, PGK-1, which, in the testes, also hybridized to PGK-2, demonstrated that the ratio of hybridization with the CA II probe to the hybridization with the PGK-1 probe was the same in the slots from deficient mice and the sibling controls (not shown).
Southern analyses ofgenomic DNA from the null homozygotes did not demonstrate any major deletions or detectable alterations of restriction fragment length sizes with a variety of restriction enzymes (Fig. 3b provides one example) .
The CA II-deficient mice have very different growth curves than their sibs (Fig. 4) , being significantly smaller than normal siblings of the same sex. Affected males eventually achieve weights comparable to those of their normal sisters but they are significantly smaller than their normal brothers.
When given tap water to drink, the urine of the deficient mice has a more alkaline pH than that of their wild-type sibs (Table 2) . Mice, like rats (20) , can tolerate large amounts of NH4Cl in their drinking water without an alteration in urine pH. The fact that neither the CA II-deficient mice nor their heterozygous sibs show a significantly lower urine pH after ingesting NH4C1 is consistent with these findings.
The null homozygotes were less tolerant of NH4C1 in the drinking water than normal sibs. The small sample size of null homozygotes studied is due to the extreme difficulty of obtaining any urine at all from them during the NH4C1 regimen. These mice looked ill, and one death occurred in tSeven males (6.0 ± 0.2) and 14 females (6.0 ± 0.2). §One death. INo urine obtainable on mice in these groups. disclosed no signs suggestive of osteopetrosis even in animals as old as 15 months (Fig. 5) . Although the skeleton is much smaller in the homozygous null mice (as expected from their decreased weight), marrow cavities are equally visible and seem proportional in size in the deficient and nondeficient mice. In addition, no brain or renal calcifications are noted by x-ray at 15 months of age in these mice. The lack of brain calcification has been confirmed by histological studies (M. S. Ghandour, personal communication). pathological state with features of the human deficiency. The mutation must be de novo since both parents and all of the siblings of the original mutant had normal CA II patterns. This mutation is most likely to have been induced with EtNU, as the Car-2 allele from the treated father is affected.
All mammalian EtNU mutations sequenced to date have been found to result from single base-pair substitutions (t, [26] [27] [28] . Lack of any rearrangements in the CA II gene detectable by Southern blotting is consistent with this mode of action of EtNU. Null mutations, including the one reported here, comprise a significant proportion of mutations induced by EtNU (29) .
The induction of a null allele by an agent causing point mutations could be due to a number of mechanisms. It is possible that the mutation in the CA II gene of these mice resulted in a nonsense codon causing premature termination of the translated protein. A missense codon resulting in a full-length, but rapidly degraded, protein could also result in a null mutation that is Crm-, such as this one.
Most of the electrophoretically detected EtNU-induced null alleles fail to show discernable physiological effects in the homozygote (29) , with the significant exception of glucose phosphate isomerase (ref. 28 ; S.E.L., unpublished data) and CA II described in this study. Animals without detectable CA II activity are viable but are seriously defective physiologically. They are smaller than their siblings of the same sex, starting not later than at 2 weeks of age. This is presumably a consequence of their renal tubular acidosis and is analogous to the human disorder in which growth is normal during infancy, but short stature and failure to thrive appear from early to middle childhood (7, 8) .
The primary difference between the syndromes in mouse and in man is the development of osteopetrosis in affected humans; there is no sign of this even in old mice. The lack of osteopetrosis may be due to the absence of a Haversian system as has been observed in rats (30) . Apparently rodents do not remodel bone the way humans do-i.e., their remodeling is limited to the surfaces of their smaller bones and does not occur internally. Thus, the lack of osteopetrosis in CA II-deficient mice, as compared to CA II-deficient humans, suggests the possibility that the function of CA IT in osteoclasts is essential for internal remodeling of bone and not for its surface deposition. Alternatively, mice may have enzymatic or physiological pathways involved in remodeling skeletal bone different from humans, in which CA II seems to be important. In fact, osteopetrosis is known to exist in microphthalmic (mi/mi) mice but levels of CA II are normal in erythrocytes and osteoclasts of such osteopetrotic (mi/mi) mice (31) .
The apparent lack of brain calcification in Car-2 homozygous null mice may be due to the relative difference in life spans of mice and humans or it may reflect a species difference for the physiological roles of CA II in maintaining acid-base balance in the brain. CA II is normally expressed in a wide variety of mouse tissues, compared with the seemingly more limited distribution of the CA I and CA III isozymes (32, 33) . In CA II-deficient humans, dysfunctions of bone (osteopetrosis) and brain (cerebral calcification) are evident; nevertheless, no evidence of abnormal function was observed in other human tissues (7) , which presumably also lack CA IT as do CA II-deficient mice. One possible explanation for the viability of individuals lacking CA II is that normally other isozymes of CA (e.g., CA I, CA ITT) may be expressed together with CA TI in certain cells and that they can substitute for CA IT in its absence. This has already been demonstrated in CA II-deficient humans, in which the CA I isozyme appears to be capable of carrying out the erythrocyte function of CA in the absence of the CA TI isozyme (34) .
The mutant null homozygous mice serve as models for the analysis of CA gene expression in mammals. The specific defect provides an opportunity to study the genetic regulation of the Car-2 locus. The null mutation also facilitates the study of tissue-specific expression of the other CA isozymes in the absence of the more abundant CA II isozyme. 
